TOKYO (Reuters) -Japan's Nissan Motor ( NSANF ) slashed its annual outlook after posting a 99% decline in first-quarter operating profit due to weak U.S. sales performance on Thursday, sending its shares sharply lower. Operating profit for the April-June period totalled 995 million yen ($6.51 million), compared with 128.6 billion yen in the same period a year earlier, far short...

July 25 (Reuters) - Anglo-Swedish drugmaker AstraZeneca ( AZN ) on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for second-quarter revenue, buoyed by demand for its therapies for cancer and rare diseases. ...

SYDNEY (Reuters) - An Australian judge said on Thursday it was not proven that an ingredient in Bayer's Roundup weedkiller increases the risk of cancer in users. ...

FRANKFURT, July 25 (Reuters) - Roche's CEO said the Swiss company is looking into potentially acquiring further obesity drug development assets even after the $2.7 billion Carmot Therapeutics takeover, agreed in December. Speaking in a media call after the release of first-half results, CEO Thomas Schinecker also said that 25% of projects in the group's drug development pipeline had been...